(Q37826427)

23 August 2017

1 reference

title

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence (English)

1 reference

23 August 2017

1 reference

2

0 references

author name string

David Balayssac

1

1 reference

23 August 2017

Juliette Descoeur

3

1 reference

23 August 2017

Bing Ling

4

1 reference

23 August 2017

Denis Pezet

5

1 reference

23 August 2017

Alain Eschalier

6

1 reference

23 August 2017

Nicolas Authier

7

1 reference

23 August 2017

language of work or name

English

0 references

publication date

6 January 2011

1 reference

Expert Opinion on Drug Safety

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

407-417

1 reference

Neurological complications of cancer chemotherapy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Peripheral neuropathy related to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Chemotherapy-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Vincristine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Paclitaxel in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Toxic neuropathy in patients with pre-existing neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Animal models of chemotherapy-evoked painful peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Description of a short-term Taxol-induced nociceptive neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Up-regulation of matrix metalloproteinase-3 in the dorsal root ganglion of rats with paclitaxel-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Calpain inhibition protects against Taxol-induced sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Docetaxel administration schedule: from fever to tears? A review of randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Peripheral neuropathy induced by microtubule-stabilizing agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Peripheral neurotoxicity induced by docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Motor neuropathy due to docetaxel and paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Docetaxel neuropathy: a distal axonopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Current perspectives of epothilones in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

An electrophysiological investigation of the effects of cisplatin and the protective actions of dexamethasone on cultured dorsal root ganglion neurones from neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Oxaliplatin-safety profile: neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thalidomide as a novel therapeutic agent: new uses for an old product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thalidomide-induced neuropathy: a ganglionopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thalidomide and sensory neurotoxicity: a neurophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

TNF-alpha expression in painful and nonpainful neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Grading of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

Neuropathy in multiple myeloma treated with thalidomide: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.543417

10.1517/14740338.2011.543417

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference